Elevated liver CYP2E1 content is implicated in various metabolic diseases including alcoholic liver disease, nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), diabetes and obesity. This evidence concerns the gene CYP2E1 and obesity due to melanocortin 4 receptor deficiency.